Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585961 · ClinicalTrials.gov registry record
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
A clinical trial, sponsored by Biosense Webster.
- Completed
- Registry status
- 511
- Enrollment target
NCT01585961 is a clinical trial that has completed, run by Biosense Webster. The registered enrollment target is 511 participants.
The verdict
NCT01585961 has completed, sponsored by Biosense Webster.
- COMPLETED
- Registry status
- 511 participants
- Enrollment target
Study Summary
This is a prospective, interventional, observational, unblinded, single-arm, multicenter registry of younger and older subjects with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.
Interventions
- DEVICE Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01585961
The ClinicalTrials.gov registry entry for NCT01585961 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 511 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biosense Webster, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter) is the first listed.
NCT01585961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01585961 about?
NCT01585961 is a clinical study titled "NAVISTAR® THERMOCOOL® SF Catheter: Observational Study". This is a prospective, interventional, observational, unblinded, single-arm, multicenter registry of younger and older subjects with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.
What is the current status of trial NCT01585961?
This trial is currently completed. The enrollment target is 511 participants. The study started on 2012-04. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01585961?
The interventions under investigation include: Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter) (DEVICE).
Who is sponsoring clinical trial NCT01585961?
This trial is sponsored by Biosense Webster, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.